ZK-Epo Given With Prednisone in Patients With Metastatic Androgen-independent Prostate Cancer
This study has been completed.
Information provided by (Responsible Party):
First received: July 7, 2006
Last updated: December 2, 2014
Last verified: December 2014
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||December 2009|
|Primary Completion Date:||September 2008 (Final data collection date for primary outcome measure)|
Beer TM, Smith DC, Hussain A, Alonso M, Wang J, Giurescu M, Roth K, Wang Y. Phase II study of first-line sagopilone plus prednisone in patients with castration-resistant prostate cancer: a phase II study of the Department of Defense Prostate Cancer Clinical Trials Consortium. Br J Cancer. 2012 Aug 21;107(5):808-13. doi: 10.1038/bjc.2012.339.